Toxic shock syndrome surveillance in UK children.

BACKGROUND: Toxic shock syndrome (TSS) is an acute toxin-mediated illness caused by toxin-producing strains of Staphylococcus aureus and Streptococcus pyogenes. There is no recent data regarding incidence, management and mortality of TSS in UK children. METHODS: Consultants from paediatric and burns units in the UK and Ireland, reported cases of TSS seen between November 2008 and December 2009, via the British Paediatric Surveillance Unit. Respondents were sent questionnaires requesting detailed information about TSS cases. Established criteria were used to divide cases into staphylococcal or streptococcal TSS. RESULTS: Forty-nine cases were identified overall; 29 cases of streptococcal TSS (18 confirmed and 11 probable) and 20 cases of staphylococcal TSS (15 confirmed and 5 probable). The incidence of TSS children in the UK & the Republic of Ireland was calculated to be 0.38 per 100 000 children. Children with staphylococcal TSS were older than those with streptococcal TSS (9.5 vs 3.8 years; p<0.003). Paediatric intensive care facilities were used for 78% of cases (invasive ventilatory support 69%; inotropic support 67%; haemofiltration 12%). Agents with antitoxin effects were underused; clindamycin 67%, intravenous immunoglobulin (IVIG) 20%, fresh frozen plasma 40%. There were eight deaths, all in the streptococcal group (28% of streptococcal cases)-none were given IVIG. CONCLUSIONS: Streptococcal TSS was as frequent as staphylococcal TSS, contrasting with previous literature. Children with streptococcal TSS had a higher mortality than those with staphylococcal TSS (28% vs 0%; p<0.05). Recommended immunomodulatory agents (IVIG and clindamycin) were underused. This study highlights the need for a guideline to improve management of TSS in children.

A survey of tuberculosis services in the UK.

AIM: To determine the provision of services for children with tuberculosis (TB) living in the UK. METHOD: A postal questionnaire was sent to the most appropriate paediatrician and adult physician in every acute hospital trust in the UK. Information was sought on inpatient and outpatient services for children with TB and for children in contact with TB. RESULTS: Responses were received from 323 individuals in 199 of the 205 trusts approached. The median number of children with TB seen per year at each trust was 1.5 (range 0-30). Inpatients were nearly all admitted to paediatric wards (197 (99%) trusts). In 141 trusts (71%) they were looked after solely by paediatricians or jointly by paediatricians and physicians (47 trusts, 24%). 132 (66%) trusts stated there was a named consultant for children with TB. Negative pressure isolation rooms were reported to be available for children in 42 trusts (21%). As outpatients, children with TB were seen in paediatric clinics in 163 (82%) trusts. Only 10 (5%) trusts had designated family TB clinics. Children in contact with TB were managed by paediatricians in 81 (38%) trusts, by physicians in 67 (34%) trusts and jointly in 51 (26%) trusts. 161 (81%) trusts had access to a TB nurse and directly observed therapy (DOTS) was available in 116 (58%) trusts. CONCLUSIONS: Many paediatricians see few children with TB, but most children with TB are looked after by general paediatricians alone. The survey supports national recommendations to develop family clinics and clinical service networks for children with TB, which may improve the care of these children.